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Abstract
Background The purpose of this study was to illustrate the additive value of computed tomography angiography (CTA)
for visualisation of the coronary venous anatomy prior to cardiac resynchronisation therapy (CRT) implantation.
Methods Eighteen patients planned for CRT implantation were prospectively included. A specific CTA protocol designed
for visualisation of the coronary veins was carried out on a third-generation dual-source CT platform. Coronary veins
were semi-automatically segmented to construct a 3D model. CTA-derived coronary venous anatomy was compared with
intra-procedural fluoroscopic angiography (FA) in right and left anterior oblique views.
Results Coronary venous CTA was successfully performed in all 18 patients. CRT implantation and FA were performed
in 15 patients. A total of 62 veins were visualised; the number of veins per patient was 3.8 (range: 2–5). Eighty-five per
cent (53/62) of the veins were visualised on both CTA and FA, while 10% (6/62) were visualised on CTA only, and 5%
(3/62) on FA only. Twenty-two veins were present on the lateral or inferolateral wall; of these, 95% (21/22) were visualised
by CTA. A left-sided implantation was performed in 13 patients, while a right-sided implantation was performed in the
remaining 2 patients because of a persistent left-sided superior vena cava with no left innominate vein on CTA.
Conclusion Imaging of the coronary veins by CTA using a designated protocol is technically feasible and facilitates the
CRT implantation approach, potentially improving the outcome.
Keywords Coronary veins · Computed tomography angiography · Fluoroscopic angiography · Cardiac resynchronisation
therapy
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What’s new?
● Coronary venous anatomy is visualised prior to car-
diac resynchronisation therapy (CRT) using a designated
computed tomography angiography (CTA) protocol.
● A high concordance (85%) in coronary venous anatomy
between CTA and fluoroscopic angiography was found.
● Coronary venous CTA additionally impacted the CRT
implantation approach in a quarter of the patients, show-
ing potential for the clinical workup in CRT.
Introduction
Despite the effectiveness of cardiac resynchronisation ther-
apy (CRT), one-third of eligible patients fail to benefit
[1]. Placing the left ventricular (LV) lead in an appro-
priate position in late activated myocardium remote from
scarring is a prerequisite for a response to CRT [2, 3].
The majority of studies investigating LV-lead placement
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have utilised echocardiography [3] and cardiac magnetic
resonance imaging (CMR) [4] to define a LV-lead target
segment pre-procedurally. The LV lead was subsequently
guided to a coronary vein in the target segment using flu-
oroscopic angiography (FA). However, the practical issue
remains that a target segment cannot be reached intra-pro-
cedurally, as not all LV segments are covered by coro-
nary venous anatomy. A recent imaging-guided CRT study
demonstrated that in half of the patients, no coronary vein
was present in the pre-defined CMR or echocardiographic
based target segment. Coronary venous anatomy is highly
variable regarding trajectory, shape and number of veins
[5, 6]. Imaging is therefore essential and can be used to
tailor LV-lead placement by pre-defining a target vein or
even considering alternative biventricular pacing options if
suboptimal conditions prevail.
FA is most commonly used for visualisation of the coro-
nary veins but is invasive, thus prohibiting pre-procedural
anticipation of patient-specific anatomy. Computed tomog-
raphy angiography (CTA) may enable three-dimensional
(3D) non-invasive visualisation of the coronary veins and
could be performed prior to CRT implantation.
The purpose of this study was to illustrate the addi-
tive value of visualisation of the coronary venous anatomy
by CTA prior to CRT implantation by (1) elucidating on
clinical cases and by (2) comparing the coronary venous
anatomy on CTA with FA.
Methods
Study population
Patients referred for a CRT device implantation were
prospectively enrolled from April to December 2017 at the
Maastricht University Medical Centre. Exclusion criteria
were standard contra-indications for CTA including severe
renal insufficiency, contrast media allergy and claustropho-
bia. The institutional Review Board approved the study
protocol and patients gave written consent for the use of
their data.
Pre-procedural computed tomography angiography
CTA images were acquired up to 1 month prior to the
scheduled CRT implantation. Scans were performed using
a third-generation dual-source CT scanner (Somatom Defi-
nition Force, Siemens Healthineers, Forchheim, Germany)
with a 2× 192× 0.6mm slice collimation; reference tube
voltage was set to 100 kVref using automated tube voltage
selection (CARE kV); and a reference quality tube current
of 400 mAs using tube current modulation software (Care-
Dose 4D). The gantry rotation time was 250ms and data
were acquired with retrospective gating (pitch: 0.15). Im-
age reconstruction was done with an individually adapted
field of view at 0.6mm slice thickness with an increment
of 0.4mm using a Bv40 kernel and iterative reconstruc-
tion (ADMIRE; strength 3). A test bolus was injected at
the level of the coronary sinus (CS) or ascending aorta
to assess optimal delay for the administration of contrast
medium (CM). Delay was calculated by time-to-peak +10
or +20s for the CS or ascending aorta, respectively. Pa-
tients received 72ml pre-warmed Iopromide 300 (Ultravist,
Bayer Healthcare, Berlin, Germany) at a flow rate of 6ml/s
followed by an 84-ml mixed bolus (20% CM/80% saline)
and a 40-ml saline flush at a flow rate of 3ml/s. Total io-
dine load was 26.6 (21.6+ 5) g. Injection pressure and total
amount of CM were monitored by a dedicated information
platform (Certegra Informatics Solution, Bayer). Coronary
venous anatomy was evaluated under supervision by a ra-
diologist with 7 years’ experience in cardiac CTA. 3D re-
constructions of the epicardium and coronary veins were
constructed using a semi-automatic segmentation approach
(Seg3D v2.4, SCI, University of Utah, USA). A 3D cardiac
model comprising the coronary veins and epicardium was
interactively shown to the implanting physician prior and
during CRT implantation to guide LV-lead placement.
Intra-procedural fluoroscopic angiography
Coronary venous anatomy was evaluated intra-procedurally
by an occlusive FA after placement of the right atrial and
right ventricular (RV) lead. The CS was cannulated using
a CS guiding catheter (Medtronic, Minneapolis, MN, USA)
under FA. After cannulation of the CS, a balloon catheter
(Medtronic) was advanced towards the proximal site of the
CS for occlusion. Once the balloon catheter was in a sta-
ble position, fluoroscopic angiograms of the coronary veins
were recorded in right anterior oblique (RAO) and left ante-
rior oblique (LAO) views (Inifinix-I, Toshiba Medical, Ot-
tawara, Tochigi, Japan). The coronary venous anatomy from
FA was evaluated together with the implanting cardiologist.
After acquisition of the fluoroscopic angiograms, the bal-
loon catheter was withdrawn from the CS and a quadripolar
or bipolar LV lead was placed in a coronary vein guided
by FA. An electrode with a low voltage threshold with-
out phrenic nerve stimulation and long electrical delay was
selected for pacing.
Data analyses
Continuous variables are expressed as mean± standard de-
viation and dichotomous variables in frequencies. The coro-
nary venous angiogram from both CTA and FA was classi-
fied according to the American Heart Association 17-seg-
ment heart model (Fig. 1). The CS tributaries from the 3D
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Fig. 1 Coronary venous clas-
sification used in the present
study shown on 3D computed
tomography angiography (CTA)
images (a) and 2D fluoroscopic
angiography (FA) images of
patient 14 (b). LAO left ante-
rior oblique, RAO right anterior
oblique
reconstructed CTA images were visually compared with
those present on FA in RAO and LAO views (supplemen-
tary Fig. I).
Results
Eighteen patients planned for CRT device implantation
were included (Tab. 1). Coronary venous CTA was suc-
cessfully performed in all 18 patients. CRT implantation
was carried out in 15 patients. In one patient CRT was
cancelled due to spontaneous recovery of LV ejection
fraction, resulting in no indication for CRT according to
current guidelines (patient 9) [1]. One patient (patient 16,
Fig. 2) was initially planned for CRT device implantation
but was treated with a dual-chamber pacemaker after sub-
optimal coronary venous anatomy on CTA. This patient
had undergone an unsuccessful CRT implantation 5 years
earlier as no lateral vein (LTV) was accessible for LV-lead
placement. The patient was referred for reconsideration of
CRT. CTA imaging revealed two major issues for conven-
tional LV-lead placement (Fig. 2). First, there was only
a single small LTV available. Second, the CS branched
into two sub-veins, further complicating cannulation of
the single vein. For these reasons, CRT implantation was
abandoned and the patient was treated with a dual-chamber
pacemaker only instead. One patient (patient 15) died prior
to the scheduled CRT implantation, unrelated to the study
protocol.
In one patient (patient 5, supplementary Fig. II) CRT im-
plantation was postponed due to the finding of a RV throm-
bus on CTA for which anticoagulant therapy was initiated.
The patient still underwent CRT implantation 6 months
post-dissolution of the RV thrombus on repeat CTA.
A standard left-sided CRT implantation approach by en-
tering the left subclavian or cephalic vein and advancing the
CRT leads to the right atrium through the left innominate
vein was used in 13 patients. A right-sided implantation
approach was carried out in the remaining 2 patients (num-
bers 4 and 10, Fig. 3) because of a persistent left-sided
superior vena cava (SVC) with no communicating left in-
nominate vein to reach the right-sided SVC from the left
subclavian vein. In patient 10, the presence of a persistent
left-sided SVC was known beforehand, and in patient 4 it
was found on coronary venous CTA. Both patients had di-
latation of the CS as a consequence of the persistent SVC.
An overview of the coronary veins present on CTA and
FA with final LV-lead placement per individual patient is
provided in Fig. 4. In one patient (patient 4, Fig. 3a) the
LV lead was initially targeted towards the anterolateral vein,
but cannulation did not succeed due to a steep angulation at
the ostium. After multiple failed attempts, the LV lead was
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Table 1 Patient characteristics
Patient characteristics (n= 18)
Demographics
Age (years) 69± 9
Male (n) 13 (72%)
BMI (kg/m2) 29± 5
Ischaemic cardiomyopathy (n) 12 (67%)
NYHA (II/III) 7/11
CMR LV function
LVEF (%) 27± 9
EDV (ml) 302± 86
ESV (ml) 234± 93
SV (ml) 69± 18
ECG characteristics
Sinus rhythm (n) 14 (78%)
Atrial fibrillation (n) 3 (17%)
Paced rhythm (n) 1 (6%)
QRS duration (ms) 145± 24
LBBB (n) 9 (50%)
BMI body mass index, CMR cardiac magnetic resonance,
ECG electrocardiogram, EDV end-diastolic volume, ESV end-systolic
volume, LBBB left bundle branch block, LV left ventricular, LVEF LV
ejection fraction, NYHA New York Heart Association, SV stroke
volume
finally placed in the inferior vein (IV). A sharp angulation
of the initial target vein (inferolateral vein (ILV)) was also
the case in patient 3 (supplementary Fig. III), where can-
nulation failed and the LV lead was finally cannulated into
the IV and advanced up to the ILV through an anastomosis.
The number of veins per patient ranged between 2 and
5. Coronary venous anatomy was extremely limited to only
two veins in patient 10 (Fig. 3b). A total of 62 veins from
16 patients with both CTA and angiographic images were
visualised. Eighty-five percent (53/62) of the veins were
visualised on CTA as well as FA, while 10% (6/62) were
visualised on CTA only, and 5% (3/62) were visible on FA
only. A total of 22 veins were present on the lateral or in-
ferolateral wall, of which 95% (21/22) were visualised by
CTA. Veins visualised on CTA only were most often lo-
cated inferiorly (4/6), while veins visualised on FA only
were small and located anterolaterally (2/3) or inferolater-
ally (1/3).
Discussion
This study illustrates the additive value of coronary venous
imaging by CTA prior to CRT implantation by elucidating
clinical cases and by comparing coronary venous anatomy
visualisation by CTA with FA.
In patients with both CTA and FA data, there was a high
concordance (85%) between coronary venous CTA and FA.
Interestingly, 10% of the veins were visualised by CTA but
not on FA, indicating that CTA may even have the capability
of identifying veins that are not shown by FA. Two-thirds
of the veins missed by FA were, however, located inferiorly,
which is usually not the preferred site of LV-lead placement.
In contrast, 95% of the ILV or LTV (the preferred veins in
CRT) were visualised by CTA. Five per cent of the veins
were only visible on FA and therefore missed on CTA.
These three veins were, however, small and not suitable for
LV-lead placement.
The relevance of coronary venous anatomy
visualisation in CRT
In about a quarter of our patients, pre-procedural cardiac
venous CTA had a major impact on the CRT implanta-
tion approach. In two patients, a right-sided implantation
was carried out due to a persistent left-sided SVC with no
left innominate vein. In one patient, implantation was post-
poned for 6 months due to a RV thrombus, and in another
patient, a dual-chamber pacemaker was implanted instead
of CRT due to unfavourable coronary venous anatomy.
Coronary venous CTA was particularly useful for the im-
planting physician by visualising the coronary veins in 3D
prior to CRT implantation, allowing anticipation of patient-
specific anatomy. The number and trajectory of coronary
veins was highly variable in our patients; in two of them,
for instance, initial target veins were inaccessible during
implantation due to steep angulations at the ostium, and in
one patient only two coronary veins were present with lim-
ited options for conventional LV-lead placement. A high
variability in coronary venous anatomy was also seen in
coronary venous CTA imaging in 121 perfusion-fixed post-
mortem human hearts [7] Remarkably, in 29% of the hearts
no coronary vein was present in the inferolateral region,
which is often the site of late activation and subsequently
a sweet-spot for LV-lead placement in CRT.
Besides CTA, coronary venous anatomy can also be vi-
sualised pre-procedurally in a subset of CRT candidates
who are already scheduled for a routine coronary angiogra-
phy using venous phase coronary angiography [8] Coronary
venous anatomy visualisation may be useful in identifying
those patients with suboptimal coronary venous anatomy
and may potentially simplify the CRT implantation proce-
dure, as it may reduce the need for extensive fluoroscopic
coronary venous angiograms. In addition to CRT, evalua-
tion of the coronary venous anatomy may also be relevant
for other procedures, including radiofrequency ablation [9]
or cell therapy [10].
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Fig. 2 A 78-year-old woman (patient 16) who had undergone an unsuccessful cardiac resynchronisation therapy implantation 5 years earlier as no
lateral vein on FA (a) was accessible for left ventricular lead placement. CTA in 3D (b) and 2D (c) revealed a single small and stenotic LTV and
CS branching. AV anterior vein, CS coronary sinus, IV inferior vein, LA left atrium, LAO left anterior oblique, LTV lateral vein, RA right atrium,
RV right ventricle
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Fig. 3 CTA and FA of
a 77-year-old woman (patient 4,
a) and a 49-year-old woman
(patient 10, b) with a left-sided
persistent superior vena cava
(SVC, red arrow) and CS dilata-
tion. Note the sharply angulated
vein (white arrow) in patient
4 (a) and the limited coronary
venous anatomy in patient
10 (b). ALV anterolateral vein,
AV anterior vein, CS coronary
sinus, ILV inferolateral vein,
IV inferior vein, LA left atrium,
LAO left anterior oblique,
RA right atrium, RAO right
anterior oblique, RV right
ventricle
Moving towards a tailored coronary venous CTA
protocol
The coronary venous anatomy has been assessed by a 4-
MDCT scanner and compared with FA in a small study of
seven patients [11] but still remains an underexposed area of
research compared to the arterial system. The greatest chal-
lenge for coronary venous imaging is determining optimal
delay for CTA acquisition after the administration of CM,
whilst still keeping the total iodine load low. Recent coro-
nary arterial CTA studies demonstrate that CM protocols
tailored to the individual patient lead to robust enhancement
patterns and reduction of the amount of CM used [12, 13].
CRT patients have low LV function, resulting in prolonged
duration for CM to reach the coronary system. Contrast
medium furthermore circulates in the body, is diluted by
blood, and the bolus disperses as it moves downstream in
the circulatory system. The coronary veins are located more
distal from the injection site in comparison with the arteries
and therefore encounter more dilution. In addition, CM-en-
hanced blood recirculates and may contribute to the overall
pattern of contrast enhancement achieved on CTA imaging.
In our coronary venous CTA protocol contrast and thus high
attenuation of the coronary veins was accomplished by ac-
curate timing of CM administration (+10s for the CS; +20s
for the ascending aorta) using a relatively low dose of CM
(26.6g iodine in total).
Future prospects
Stimulating the correct LV pacing site remains a critical
factor for response to CRT. The need for sites of late acti-
vation remote from scarring, acceptable pacing thresholds
without phrenic nerve stimulation, limited and suboptimal
coronary venous anatomy places major constraints on the
available LV pacing sites. In case of limited coronary ve-
nous anatomy or extensive scarring around the veins, al-
ternative approaches for biventricular pacing could be con-
sidered, including endocardial pacing [14, 15], trans-septal
pacing [16] or epicardial pacing using a minimally invasive
video-assisted thoracic surgical approach [17].
In this study, we focussed primarily on coronary venous
anatomy imaging. However, additional advantage could be
taken from CT in the context of CRT by incorporating
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Fig. 4 Coronary veins on CTA and FA with final left ventricular lead
position. ALV anterolateral vein, AV anterior vein, CS coronary sinus,
ILV inferolateral vein, IV inferior vein, LTV lateral vein, RV right ven-
tricle, SVC superior vena cava
wall thinning, wall motion [18] or delayed enhancement
as a metric of myocardial scarring. Imaging of coronary
venous anatomy together with dyssynchrony metrics and
myocardial scarring using only CT prior to CRT was very
recently performed in 54 patients by Truong et al. [19].
This is particularly relevant in patients with already exist-
ing pacing systems [20] in which CMR is contra-indicated.
An additional potential advantage of CTA may be visuali-
sation of the phrenic nerve [21] in relation to the coronary
venous anatomy, to avoid phrenic nerve stimulation around
the LV lead.
Limitations
This is a single-centre study using a limited number of pa-
tients. However, coronary venous CTA already impacted on
a substantial percentage of the CRT implantations, indicat-
ing that CTA prior to CRT may be of important clinical
value. CM should be used with caution in patients with
severe kidney dysfunction; however CM doses were kept
low.
Conclusion
Visualisation of the coronary venous anatomy by CTA is
representative of the anatomy recorded intra-procedurally
under FA and has additive value for CRT implantation.
CTA allows patient-specific anticipation of coronary ve-
nous anatomy and determination of relevant LV-lead pacing
sites, making it a diagnostic of high potential in CRT.
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